AIR340B Releases Study Criticizing DSH Hospital Commitment to the Underserved

Drug distributor AmerisourceBergen’s business consulting unit Xcenda has written an issue brief for drug industry-led group AIR340B saying Congress and the executive branch should revise 340B eligibility standards to keep 340B “from being used solely as a profit center for hospitals and pharmacies that do not serve low-income and underserved patients in the communities where they live.”